Investor Day 2026
Watch Investor Day by Chapter
1.) Intro & Overview (Pravin U. Dugel, MD)
2.) SOL-1 Data & Clinical Program Review (Nadia K. Waheed, MD, MPH)
3.) U.S. Regulatory Strategy in Wet AMD (Peter K. Kaiser, MD)
4.) NDA Submission Strategy (Peter K. Kaiser, MD & Arthur Ciociola, PhD)
5.) Preparing for a Successful Launch (David Robinson)
6.) SOL-R- Defining Non-Inferiority Success (Jeffrey S. Heier, MD)
7.) KOL Perspectives (Featuring Arshad Khanani, MD; Lejla Vajzovic, MD; Darius Moshfeghi, MD)
8.) Summary & Takeaways (Pravin U. Dugel, MD)
9.) Audience Q&A (All)
SOL-1 Phase 3 Data Presentation at APVRS
SOL-1 Phase 3 Data Presentation at Macula Society
New Data Analysis
Download Presentation 198.4 KB
All investigational product candidates are currently undergoing clinical evaluation. This content is not intended to convey any conclusion of safety or efficacy, and there is no guarantee that any product candidate will successfully complete development or gain FDA approval or other regulatory authority approval.
Upcoming Events
Recent Events anchor do not remove
Recent Events
September 15, 2026 at 10:50 AM EDT
Webcast Replay 43.8 MB
July 22, 2026 at 2:30 PM EDT
June 17, 2026 at 2:00 PM EDT